Xeno Transplants Corp. operates as a bio-technology research and development company. The company is headquartered in Vancouver, British Columbia and currently employs 0 full-time employees. The company went IPO on 2006-08-01. Xenotransplantation is defined as the transplantation of organs, cells and tissues from one species to another. The firm has one reportable segment, which is the development of products to address the shortage of human donor cells and organs for transplantation into patients. All the Company’s activities are located in the United States. The firm intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.
Follow-Up Questions
Xeno Aeronautics Corp のCEOは誰ですか？
Elliot Lebowitz は Xeno Aeronautics Corp の President で、2007 から在籍しています。
XENO の株価パフォーマンスは？
XENO の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Xeno Aeronautics Corp の主な事業テーマや業界は？
Xeno Aeronautics Corp は Biotechnology 業界、セクターは Health Care に属しています。
